Andrew Grey , Alison Avenell , Alan Gaby , Mark J. Bolland
{"title":"出版商对已发表研究证据和建议改进的完整性问题的反应不一致。","authors":"Andrew Grey , Alison Avenell , Alan Gaby , Mark J. Bolland","doi":"10.1016/j.jclinepi.2025.111918","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>To collate, review, and comment upon publishers’ response to integrity concerns.</div></div><div><h3>Study Design and Setting</h3><div>We conducted a narrative review of publications reporting the responses of publishers to concerns about the integrity of research published in their journals. We also drew upon extensive personal experience and a new analysis of publisher responses to integrity concerns about 172 clinical trial publications by a single research group 5 years after the concerns were raised simultaneously with affected publishers.</div></div><div><h3>Results</h3><div>Existing evidence reports that slow, incomplete, and opaque responses from publishers to integrity concerns are common, in both clinical and preclinical disciplines. When we raised very similar concerns about a large set of journal articles simultaneously with publishers, times to resolution varied markedly, and outcomes ranged from no editorial action to all papers retracted.</div></div><div><h3>Conclusion</h3><div>Publishers' responses to notification of concerns about the integrity of publications in their journals are markedly inconsistent, both in their timing and the nature of their editorial decisions. The reasons for these inconsistencies are unknown but could be addressed by a collaborative and transparent process involving publisher integrity staff and academics with expertise in publication integrity. Understanding the reasons for the disparate outcomes is likely to facilitate improvements which will enhance the trustworthiness of the biomedical literature.</div></div><div><h3>Plain Language Summary</h3><div>Existing evidence reports that publishers are slow to assess concerns about the reliability of research publications, and their assessments produce markedly inconsistent outcomes. Our finding of widely disparate outcomes of publisher assessments of overlapping concerns about 172 clinical trials by a single research group reinforces this point. Improving the timeliness, transparency, and systematicity of publisher assessments is likely to enhance the reliability of published research.</div></div>","PeriodicalId":51079,"journal":{"name":"Journal of Clinical Epidemiology","volume":"186 ","pages":"Article 111918"},"PeriodicalIF":5.2000,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Inconsistency in publishers' responses to integrity concerns about published research. Evidence and suggested improvements\",\"authors\":\"Andrew Grey , Alison Avenell , Alan Gaby , Mark J. Bolland\",\"doi\":\"10.1016/j.jclinepi.2025.111918\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><div>To collate, review, and comment upon publishers’ response to integrity concerns.</div></div><div><h3>Study Design and Setting</h3><div>We conducted a narrative review of publications reporting the responses of publishers to concerns about the integrity of research published in their journals. We also drew upon extensive personal experience and a new analysis of publisher responses to integrity concerns about 172 clinical trial publications by a single research group 5 years after the concerns were raised simultaneously with affected publishers.</div></div><div><h3>Results</h3><div>Existing evidence reports that slow, incomplete, and opaque responses from publishers to integrity concerns are common, in both clinical and preclinical disciplines. When we raised very similar concerns about a large set of journal articles simultaneously with publishers, times to resolution varied markedly, and outcomes ranged from no editorial action to all papers retracted.</div></div><div><h3>Conclusion</h3><div>Publishers' responses to notification of concerns about the integrity of publications in their journals are markedly inconsistent, both in their timing and the nature of their editorial decisions. The reasons for these inconsistencies are unknown but could be addressed by a collaborative and transparent process involving publisher integrity staff and academics with expertise in publication integrity. Understanding the reasons for the disparate outcomes is likely to facilitate improvements which will enhance the trustworthiness of the biomedical literature.</div></div><div><h3>Plain Language Summary</h3><div>Existing evidence reports that publishers are slow to assess concerns about the reliability of research publications, and their assessments produce markedly inconsistent outcomes. Our finding of widely disparate outcomes of publisher assessments of overlapping concerns about 172 clinical trials by a single research group reinforces this point. Improving the timeliness, transparency, and systematicity of publisher assessments is likely to enhance the reliability of published research.</div></div>\",\"PeriodicalId\":51079,\"journal\":{\"name\":\"Journal of Clinical Epidemiology\",\"volume\":\"186 \",\"pages\":\"Article 111918\"},\"PeriodicalIF\":5.2000,\"publicationDate\":\"2025-08-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Epidemiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0895435625002513\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Epidemiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0895435625002513","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
Inconsistency in publishers' responses to integrity concerns about published research. Evidence and suggested improvements
Objectives
To collate, review, and comment upon publishers’ response to integrity concerns.
Study Design and Setting
We conducted a narrative review of publications reporting the responses of publishers to concerns about the integrity of research published in their journals. We also drew upon extensive personal experience and a new analysis of publisher responses to integrity concerns about 172 clinical trial publications by a single research group 5 years after the concerns were raised simultaneously with affected publishers.
Results
Existing evidence reports that slow, incomplete, and opaque responses from publishers to integrity concerns are common, in both clinical and preclinical disciplines. When we raised very similar concerns about a large set of journal articles simultaneously with publishers, times to resolution varied markedly, and outcomes ranged from no editorial action to all papers retracted.
Conclusion
Publishers' responses to notification of concerns about the integrity of publications in their journals are markedly inconsistent, both in their timing and the nature of their editorial decisions. The reasons for these inconsistencies are unknown but could be addressed by a collaborative and transparent process involving publisher integrity staff and academics with expertise in publication integrity. Understanding the reasons for the disparate outcomes is likely to facilitate improvements which will enhance the trustworthiness of the biomedical literature.
Plain Language Summary
Existing evidence reports that publishers are slow to assess concerns about the reliability of research publications, and their assessments produce markedly inconsistent outcomes. Our finding of widely disparate outcomes of publisher assessments of overlapping concerns about 172 clinical trials by a single research group reinforces this point. Improving the timeliness, transparency, and systematicity of publisher assessments is likely to enhance the reliability of published research.
期刊介绍:
The Journal of Clinical Epidemiology strives to enhance the quality of clinical and patient-oriented healthcare research by advancing and applying innovative methods in conducting, presenting, synthesizing, disseminating, and translating research results into optimal clinical practice. Special emphasis is placed on training new generations of scientists and clinical practice leaders.